Prothena to Present New Data from Alzheimer's Disease Programs at Alzheimer's Association International Conference® 2023 (AAIC®)

Prothena Corporation plc , a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein dysregulation expertise, today announced participation...

Related Keywords

Netherlands ,Amsterdam ,Noord Holland ,Ferenc Mart ,Brian Campbell ,Head Of Neurodegeneration Clinical Development ,Prothena Corporation ,Alzheimer Association International Conference ,Nasdaq ,Exchange Commission ,Company On Twitter Prothenacorp ,International Conference On Alzheimer ,Association International ,Potential Treatment ,Neurodegeneration Clinical Development ,Translational Medicine ,What Progress ,People Living ,Quarterly Report ,Markets ,